Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Data Supplement
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by del Aguila, M.A.
Right arrow Articles by van Belle, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by del Aguila, M.A.
Right arrow Articles by van Belle, G.
Related Collections
Right arrow Prognosis
Right arrow All Neuromuscular Disease
Right arrow Amyotrophic lateral sclerosis
Right arrow All epidemiology

Neurology 2003;60:813-819
© 2003 American Academy of Neurology

Prognosis in amyotrophic lateral sclerosis

A population-based study M.A. del Aguila, PhD, W.T. Longstreth, Jr, MD MPH, V. McGuire, PhD, T.D. Koepsell, MD MPH and G. van Belle, PhD

From the Departments of Dental Public Health Sciences (Dr. del Aguila), Neurology (Dr. Longstreth), Epidemiology (Drs. del Aguila, Longstreth, McGuire, and Koepsell), Health Services (Dr. Koepsell), Environmental Health (Dr. van Belle), and Biostatistics (Dr. van Belle), University of Washington, Seattle.

Address correspondence and reprint requests to Dr. Longstreth, Department of Neurology, Box 359775, Harborview Medical Center, 325 Ninth Avenue, Seattle, WA 98104-2420; e-mail: wl{at}u.washington.edu

Background: Accurate information on prognosis of ALS is useful to patients, families, and clinicians.

Methods: In a population-based study of ALS in western Washington, the authors assembled a cohort of 180 patients with incident ALS between 1990 and 1994. Information on potential prognostic factors was collected during an in-person interview. Patients also completed the Medical Outcomes Study Short Form 36 (SF-36). Vital status through December 1999 was known for all patients.

Results: Median survival was 32 months from onset of symptoms and 19 months from diagnosis. The 5-year survival after diagnosis was 7%. Older age and female sex were strongly associated with poor survival. In multivariable Cox proportional hazards regression models, factors significantly and independently associated with a worse prognosis included older age, any bulbar features at onset, shorter time from symptom onset to diagnosis, lack of a marital partner, and residence in King County. Recursive partitioning identified age, time from symptom onset to diagnosis, and marital status as the strongest predictors of survival. Good summary scores for physical health on the SF-36, but not for mental health, were significantly associated with longer survival than poor scores.

Conclusion: These findings are consistent with other population-based studies of ALS and confirm its pernicious nature. Older age, female sex, any bulbar features at onset, short time from symptom onset to diagnosis, lack of a marital partner, and disease severity are key prognostic factors. Serial measurement of severity would likely improve predictions.




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M G Weisskopf, N Morozova, E J O'Reilly, M L McCullough, E E Calle, M J Thun, and A Ascherio
Prospective study of chemical exposures and amyotrophic lateral sclerosis
J. Neurol. Neurosurg. Psychiatry, May 1, 2009; 80(5): 558 - 561.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
F. Fang, U. Valdimarsdottir, R. Bellocco, L.-O. Ronnevi, P. Sparen, K. Fall, and W. Ye
Amyotrophic Lateral Sclerosis in Sweden, 1991-2005
Arch Neurol, April 1, 2009; 66(4): 515 - 519.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
L. C. Wijesekera, S. Mathers, P. Talman, C. Galtrey, M. H. Parkinson, J. Ganesalingam, E. Willey, M. A. Ampong, C. M. Ellis, C. E. Shaw, et al.
Natural history and clinical features of the flail arm and flail leg ALS variants
Neurology, March 24, 2009; 72(12): 1087 - 1094.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
F. Fang, U. Valdimarsdottir, C. J. Furst, C. Hultman, K. Fall, P. Sparen, and W. Ye
Suicide among patients with amyotrophic lateral sclerosis
Brain, October 1, 2008; 131(10): 2729 - 2733.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S X Xie, M S Forman, J Farmer, P Moore, Y Wang, X Wang, C M Clark, H B Coslett, A Chatterjee, S E Arnold, et al.
Factors associated with survival probability in autopsy-proven frontotemporal lobar degeneration
J. Neurol. Neurosurg. Psychiatry, February 1, 2008; 79(2): 126 - 129.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Zoccolella, I. L. Simone, P. Lamberti, V. Samarelli, R. Tortelli, L. Serlenga, and G. Logroscino
Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis
Neurology, January 15, 2008; 70(3): 222 - 225.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S Zoccolella, E Beghi, G Palagano, A Fraddosio, V Guerra, V Samarelli, V Lepore, I L Simone, P Lamberti, L Serlenga, et al.
Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study
J. Neurol. Neurosurg. Psychiatry, January 1, 2008; 79(1): 33 - 37.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. Grossman, E. M. Wood, P. Moore, M. Neumann, L. Kwong, M. S. Forman, C. M. Clark, L. F. McCluskey, B. L. Miller, V. M.-Y. Lee, et al.
TDP-43 Pathologic Lesions and Clinical Phenotype in Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions
Arch Neurol, October 1, 2007; 64(10): 1449 - 1454.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Bordet, B. Buisson, M. Michaud, C. Drouot, P. Galea, P. Delaage, N. P. Akentieva, A. S. Evers, D. F. Covey, M. A. Ostuni, et al.
Identification and Characterization of Cholest-4-en-3-one, Oxime (TRO19622), a Novel Drug Candidate for Amyotrophic Lateral Sclerosis
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 709 - 720.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. Visser, R. M. van den Berg-Vos, H. Franssen, L. H. van den Berg, J. H. Wokke, J. M. Vianney de Jong, R. Holman, R. J. de Haan, and M. de Visser
Disease Course and Prognostic Factors of Progressive Muscular Atrophy
Arch Neurol, April 1, 2007; 64(4): 522 - 528.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. J. Sorenson, J. Mandrekar, B. Crum, and J. C. Stevens
Effect of referral bias on assessing survival in ALS
Neurology, February 20, 2007; 68(8): 600 - 602.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. Beghi, A. Millul, A. Micheli, E. Vitelli, G. Logroscino, and for the SLALOM Group
Incidence of ALS in Lombardy, Italy
Neurology, January 9, 2007; 68(2): 141 - 145.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Czaplinski, L. J. Haverkamp, A. A. Yen, E. P. Simpson, E. C. Lai, and S. H. Appel
The value of database controls in pilot or futility studies in ALS
Neurology, November 28, 2006; 67(10): 1827 - 1832.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S Kalra, A Vitale, N R Cashman, A Genge, and D L Arnold
Cerebral degeneration predicts survival in amyotrophic lateral sclerosis
J. Neurol. Neurosurg. Psychiatry, November 1, 2006; 77(11): 1253 - 1255.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
F. Kimura, C. Fujimura, S. Ishida, H. Nakajima, D. Furutama, H. Uehara, K. Shinoda, M. Sugino, and T. Hanafusa
Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS
Neurology, January 24, 2006; 66(2): 265 - 267.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
V. Meininger, B. Asselain, P. Guillet, P. N. Leigh, A. Ludolph, L. Lacomblez, W. Robberecht, and for the Pentoxifylline European Group
Pentoxifylline in ALS: A double-blind, randomized, multicenter, placebo-controlled trial
Neurology, January 10, 2006; 66(1): 88 - 92.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
M. G. Weisskopf, M. L. McCullough, N. Morozova, E. E. Calle, M. J. Thun, and A. Ascherio
Prospective Study of Occupation and Amyotrophic Lateral Sclerosis Mortality
Am. J. Epidemiol., December 15, 2005; 162(12): 1146 - 1152.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
P J Shaw
Molecular and cellular pathways of neurodegeneration in motor neurone disease
J. Neurol. Neurosurg. Psychiatry, August 1, 2005; 76(8): 1046 - 1057.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. G. Weisskopf, E. J. O'Reilly, M. L. McCullough, E. E. Calle, M. J. Thun, M. Cudkowicz, and A. Ascherio
Prospective study of military service and mortality from ALS
Neurology, January 11, 2005; 64(1): 32 - 37.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
M. G. Weisskopf, M. L. McCullough, E. E. Calle, M. J. Thun, M. Cudkowicz, and A. Ascherio
Prospective Study of Cigarette Smoking and Amyotrophic Lateral Sclerosis
Am. J. Epidemiol., July 1, 2004; 160(1): 26 - 33.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Chio, R. Mutani, G. Mora, W.T. Longstreth Jr., and M.A. del Aguila
Prognosis in amyotrophic lateral sclerosis: A population-based study
Neurology, December 23, 2003; 61(12): 1826 - 1827.
[Full Text] [PDF]


Home page
Evid. Based Nurs.Home page
OTHER ARTICLES NOTED (24 Jan 03 to 18 Apr 03)
Evid. Based Nurs., July 1, 2003; 6(3): e1 - 12.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

Reply to Letter to the Editor
WT Longstreth, et al.
Neurology Online, 16 Jul 2003 [Full text]
Prognosis in amyotrophic lateral sclerosis: A population-based study
Adriano Chio, et al.
Neurology Online, 16 Jul 2003 [Full text]